Bexxar Corixa Corporation - Treatment for Non-Hodgkin’s Lymphoma
Bexxar is a dual-action therapy that combines the tumor-targeting ability of a cytotoxic monoclonal antibody and the therapeutic potential of radiation. Bexxar is indicated for the treatment of Non-Hodgkin’s lymphoma.Posted: June 2003

